Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lexiscan for Myocardial Stress Perfusion CT
NCT03103061Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Feb 2016
- Primary completion
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of regadenoson in coronary artery disease (CAD), sponsored by Medical University of South Carolina. Primary endpoint: Number of Treatment-related Adverse Events at 30 days. Started Feb 2016; status: completed.
02
Drugs
regadenoson
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03103061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03103061.